| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Maj M | |
| Henderson J | |||
| Sartorius N | |||
| Leucht S | |||
| Burkard T | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 317-333 | |
| P577 | publication date | 2007-11-01 | |
| P1433 | published in | Acta Psychiatrica Scandinavica | Q4033348 |
| P1476 | title | Physical illness and schizophrenia: a review of the literature | |
| P478 | volume | 116 |
| Q59800563 | A 16-Year Cohort Analysis of Autism Spectrum Disorder-Associated Morbidity in a Pediatric Population |
| Q35922175 | A Population-Based Cohort Study on Peripheral Arterial Disease in Patients with Schizophrenia |
| Q42378933 | A comparison of passive and active estimates of sleep in a cohort with schizophrenia |
| Q37998841 | A critical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implications |
| Q42928643 | A head-to-head comparison of sertindole and risperidone on metabolic parameters |
| Q50754092 | A medical-surgical nurse's perceptions of caring for a person with severe mental illness. |
| Q38231654 | A meta-analysis of prevalence estimates and moderators of low bone mass in people with schizophrenia |
| Q38179063 | A systematic review of controlled interventions to reduce overweight and obesity in people with schizophrenia. |
| Q64079018 | A systematic review of palliative care tools and interventions for people with severe mental illness |
| Q47672828 | Access to specialist palliative care services by people with severe and persistent mental illness: A retrospective cohort study. |
| Q58313442 | Acute general hospital admissions in people with serious mental illness |
| Q47983844 | Addressing Physical Health Needs of Individuals With Schizophrenia Using Orem's Theory |
| Q47926819 | Adverse Events in Childhood as a Risk Factor for Elevated BMI among People with Schizophrenia and Bipolar Disorder |
| Q64120957 | An Integrative Program to Reduce Stigma in Primary Healthcare Workers Toward People With Diagnosis of Severe Mental Disorders: A Protocol for a Randomized Controlled Trial |
| Q48908840 | An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses |
| Q38777321 | Antipsychotic Trials in Schizophrenia from India: A Systematic Review and Meta-analysis |
| Q50617989 | Antipsychotic exposure prior to acute myocardial infarction in patients with serious mental illness. |
| Q39233778 | Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis |
| Q48299118 | Antipsychotics use: 2006-2013 trends in prevalence and incidence and characterization of users. |
| Q33160123 | Assessing QT interval prolongation and its associated risks with antipsychotics. |
| Q47568514 | Assessment of cardiovascular risk in an Italian psychiatric outpatient sample: A chart review of patients treated with second-generation antipsychotics. |
| Q37077980 | Association between psychiatric disorders and osteoarthritis: a nationwide longitudinal population-based study |
| Q34625474 | Association between schizophrenia and urinary calculi: a population-based case-control study |
| Q92934869 | Association of Genetic Risk for Rheumatoid Arthritis With Cognitive and Psychiatric Phenotypes Across Childhood and Adolescence |
| Q57403239 | Associations Between Non-neurological Autoimmune Disorders and Psychosis: A Meta-analysis |
| Q36527649 | Associations between health risk behaviors and symptoms of schizophrenia and bipolar disorder: a systematic review |
| Q36325409 | Asthma, corticosteroid use and schizophrenia: A nationwide population-based study in Taiwan |
| Q36631551 | Attitudes toward metabolic adverse events among patients with schizophrenia in Japan |
| Q50713067 | Attitudes towards patients with mental illness in Irish medical students. |
| Q37498113 | Atypical antipsychotic use is an independent predictor for the increased mean platelet volume in patients with schizophrenia: A preliminary study |
| Q44127395 | Back to basics: informing the public of co-morbid physical health problems in those with mental illness |
| Q36388181 | Body composition in patients with schizophrenia: Comparison with healthy controls |
| Q46517339 | Body mass index and prevalence of obesity in a French cohort of patients with schizophrenia |
| Q34660592 | Body mass index and quality of life among outpatients with schizophrenia in Japan |
| Q92001362 | Bone mineral density and general health of long-term residential psychiatric inpatients |
| Q37769756 | Cancer diagnosis in people with severe mental illness: practical and ethical issues |
| Q30249107 | Cancer in patients with schizophrenia: What is the next step? |
| Q55052000 | Cancer mortality in patients with schizophrenia: an 11-year prospective cohort study. |
| Q51871881 | Cardiovascular disease and diabetes in people with severe mental illness. |
| Q36714070 | Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort study |
| Q37573443 | Cardiovascular disease risk in schizophrenia patients: a case control study |
| Q30949176 | Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial |
| Q33756112 | Care provided by general practitioners to patients with psychotic disorders: a cohort study |
| Q36690993 | Cider house rules |
| Q36328767 | Clinicians' adherence to clinical practice guidelines for cardiac function monitoring during antipsychotic treatment: a retrospective report on 434 patients with severe mental illness. |
| Q47429942 | Clozapine, Diabetes Mellitus, Cardiovascular Risk and Mortality: Results of a 21-year Naturalistic Study in Patients with Schizophrenia and Schizoaffective Disorder. |
| Q45331506 | Co-occurring medical and mental illness and substance use disorders among veteran clinic users with spinal cord injury patients with complexities |
| Q30891577 | Comorbid somatic illnesses in psychiatric inpatients - an analysis of administrative data |
| Q37621945 | Comparison of predictive equations for resting energy expenditure among patients with schizophrenia in Japan |
| Q35154145 | Consensus building to improve the physical health of people with severe mental illness: a qualitative outcome mapping study |
| Q47253637 | Converging evidence that sequence variations in the novel candidate gene MAP2K7 (MKK7) are functionally associated with schizophrenia |
| Q92065615 | Cost-Effectiveness Evaluations of Psychological Therapies for Schizophrenia and Bipolar Disorder: A Systematic Review |
| Q50775101 | Cost-efficiency of laboratory testing among psychiatric inpatients. |
| Q45140327 | Cultural diversity in physical diseases among patients with mental illnesses |
| Q26743371 | DNA Damage and Repair in Schizophrenia and Autism: Implications for Cancer Comorbidity and Beyond |
| Q91677495 | Development and implementation of electronic medical handovers across psychiatric hospitals: quality improvement initiative |
| Q38179046 | Diagnosis and treatment of sleep apnoea in women with schizophrenia |
| Q34450505 | Diagnostic overshadowing and other challenges involved in the diagnostic process of patients with mental illness who present in emergency departments with physical symptoms--a qualitative study |
| Q24186009 | Dietary advice for people with schizophrenia |
| Q91581338 | Disparities in cancer screening in people with mental illness across the world versus the general population: prevalence and comparative meta-analysis including 4 717 839 people |
| Q87911567 | Disparities in the management of cardiovascular risk factors in patients with psychiatric disorders: a systematic review and meta-analysis |
| Q35993230 | Do routine outcome monitoring results translate to clinical practice? A cross-sectional study in patients with a psychotic disorder |
| Q37293621 | Does Schizophrenia in Offspring Increase the Risk of Developing Alzheimer's Dementia |
| Q64252129 | Double-Edged Sword of Tumour Suppressor Genes in Schizophrenia |
| Q49110698 | Early death and CSF monoamine metabolites in schizophrenia spectrum psychosis |
| Q90136385 | Early environmental factors and somatic comorbidity in schizophrenia and nonschizophrenic psychoses: A 50-year follow-up of the Northern Finland Birth Cohort 1966 |
| Q35754726 | Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder |
| Q30852787 | Effects of childhood and adolescence physical activity patterns on psychosis risk-a general population cohort study |
| Q30493532 | Effects of plasma magnesium and prolactin on quantitative ultrasound measurements of heel bone among schizophrenic patients |
| Q47887120 | Effects of the diagnostic label 'schizophrenia', actively used or passively accepted, on general practitioners' views of this disorder |
| Q35290463 | Efficacy of lifestyle interventions in physical health management of patients with severe mental illness |
| Q35845646 | Emergency Psychiatry: Clinical and Training Approaches |
| Q34024544 | Emergency department utilization among Medicaid beneficiaries with schizophrenia and diabetes: the consequences of increasing medical complexity |
| Q38979590 | Enabling healthy living: Experiences of people with severe mental illness in psychiatric outpatient services |
| Q33498111 | European network for promoting the physical health of residents in psychiatric and social care facilities (HELPS): background, aims and methods |
| Q98564483 | Evaluation of an exercise physiology service in a youth mental health service |
| Q35968781 | Excess Mortality in Patients with Severe Mental Disorders in 1996-2010 in Finland |
| Q44468927 | Exercise capacity and quality of life in patients with schizophrenia |
| Q33639130 | Exercise practices in individuals at clinical high risk of developing psychosis |
| Q33600284 | Exercise therapy in adults with serious mental illness: a systematic review and meta-analysis |
| Q33657397 | Factors associated with dental caries among institutionalized residents with schizophrenia in Taiwan: a cross-sectional study |
| Q37438727 | Gene-environment interaction effects on lung function- a genome-wide association study within the Framingham heart study |
| Q37213547 | General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial. |
| Q38344604 | Genetic studies of schizophrenia: an update |
| Q43576204 | Genetic variations in the ADAMTS12 gene are associated with schizophrenia in Puerto Rican patients of Spanish descent |
| Q34631699 | Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices. |
| Q50618935 | Health behaviour interventions should not neglect people with serious mental health problems. |
| Q37954406 | Hospitalized mental health patients and oral health. |
| Q35882022 | How does a history of psychiatric hospital care influence access to coronary care: a cohort study |
| Q35213673 | How much do we know about schizophrenia and how well do we know it? Evidence from the Schizophrenia Library |
| Q92164026 | Impact of CHRNA5 polymorphisms on the risk of schizophrenia in the Chinese Han population |
| Q47759983 | Improving quality of life and physical health in patients with schizophrenia: A 30-month program carried out in a real-life setting |
| Q50644723 | Improving the physical health of long-term psychiatric inpatients. |
| Q34086096 | Incident somatic comorbidity after psychosis: results from a retrospective cohort study based on Flemish general practice data |
| Q34248044 | Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions. |
| Q50740986 | Increased prevalence of chronic physical health disorders in Australians with diagnosed mental illness. |
| Q55669706 | Inequitable Physical Illness and Premature Mortality for People with Severe Mental Illness in Australia: A Social Analysis. |
| Q30422062 | Inflammation and the two-hit hypothesis of schizophrenia |
| Q37865388 | Integrating primary care services into psychiatric care settings: a review of the literature |
| Q47555044 | Internal Medicine Residents' Attitudes Toward Simulated Depressed Cardiac Patients During an Objective Structured Clinical Examination: A Randomized Study |
| Q37940519 | International Organization of Physical Therapy in Mental Health consensus on physical activity within multidisciplinary rehabilitation programmes for minimising cardio-metabolic risk in patients with schizophrenia |
| Q48029738 | Intervention to promote physical health in staff within mental health facilities and the impact on patients' physical health |
| Q57689844 | Interventions to encourage uptake of cancer screening for people with severe mental illness |
| Q24201183 | Interventions to encourage uptake of cancer screening for people with severe mental illness |
| Q24203756 | Interventions to encourage uptake of cancer screening for people with severe mental illness |
| Q85827349 | Inverse association between cancer risks and age in schizophrenic patients: a 12-year nationwide cohort study |
| Q38271298 | Investigational drugs for anxiety in patients with schizophrenia |
| Q86884573 | Is low individual socioeconomic status (SES) in high-SES areas the same as low individual SES in low-SES areas: a 10-year follow-up schizophrenia study |
| Q34400040 | Is serious mental illness associated with earlier death among persons with HIV? Ten year follow up in Maryland Medicaid Recipients |
| Q96692092 | Keeping Our Staff In Mind: dietary results of a lifestyle intervention targeting mental health staff |
| Q47551405 | Lifestyles of Patients with Functional Psychosis Compared to Those of a Sample of the Regional General Population: Findings from a Study in a Community Mental Health Service of the Veneto Region, Italy |
| Q45226765 | Lower Mortality Among Stroke Patients With Schizophrenia: A Nationwide Population-Based Study |
| Q30993822 | Markers of thrombogenesis are activated in unmedicated patients with acute psychosis: a matched case control study |
| Q58806171 | Master's level mental health nursing competencies, a prerequisite for equal health among service users in mental health care |
| Q37484777 | Matrix Metalloproteinase-9 (MMP9)-A Mediating Enzyme in Cardiovascular Disease, Cancer, and Neuropsychiatric Disorders |
| Q39161509 | Medical Co-morbidities Among Patients with Severe Mental Illnesses in a Community Health Facility in Nigeria |
| Q38561965 | Mental health starts with physical health: current status and future directions of non-pharmacological interventions to improve physical health in first-episode psychosis |
| Q37465561 | Mental health status and gender as risk factors for onset of physical illness over 10 years |
| Q42128026 | Mental illness-related stigma in healthcare: Barriers to access and care and evidence-based solutions |
| Q51391762 | Metabolic parameters in the short- and long-term treatment of schizophrenia with sertindole or risperidone |
| Q37129646 | Metabolic syndrome in people with schizophrenia: a review. |
| Q83264797 | Mortality and causes of death in older patients with schizophrenia |
| Q50632877 | Mortality of people suffering from mental illness: a study of a cohort of patients hospitalised in psychiatry in the north of France. |
| Q38750676 | Motivation for physical activity and exercise in severe mental illness: A systematic review of intervention studies |
| Q47725134 | Multiple physical healthcare needs among outpatients with schizophrenia: findings from a health examination study |
| Q38584812 | New perspectives on schizophrenia in later life: implications for treatment, policy, and research |
| Q34311623 | Non-synonymous variants in the AMACR gene are associated with schizophrenia |
| Q36592205 | Osteoporosis and fracture risk in people with schizophrenia |
| Q33633124 | Outcomes of anticoagulation therapy in patients with mental health conditions |
| Q34726953 | Past and Present Progress in the Pharmacologic Treatment of Schizophrenia |
| Q43043460 | Patterns of clozapine prescribing in a mental health service in New Zealand |
| Q89692219 | Physical Illnesses Before Diagnosed as Schizophrenia: A Nationwide Case-Control Study |
| Q40786853 | Physical activity in adolescents who later developed schizophrenia: A prospective case-control study from the Young-HUNT. |
| Q42251217 | Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions. |
| Q47561828 | Physical comorbidity in schizophrenia & its correlates |
| Q33761743 | Physical disease in schizophrenia: a population-based analysis in Spain |
| Q37771645 | Physical health management in psychiatric settings |
| Q34623350 | Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. |
| Q46769024 | Physical illness in psychiatric inpatients: comparison of patients with and without substance use disorders |
| Q38635792 | Potential serotonergic agents for the treatment of schizophrenia |
| Q36795862 | Predictive models to estimate utility from clinical questionnaires in schizophrenia: findings from EuroSC. |
| Q34708413 | Prevalence and severity of antipsychotic related constipation in patients with schizophrenia: a retrospective descriptive study |
| Q34822992 | Prevalence of metabolic syndrome according to the presence of negative symptoms in patients with schizophrenia |
| Q36621075 | Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis |
| Q36406145 | Primary care consultation rates among people with and without severe mental illness: a UK cohort study using the Clinical Practice Research Datalink |
| Q38469831 | Promoting physical health for people with schizophrenia by reducing disparities in medical and dental care. |
| Q50549199 | Promoting physical health in severe mental illness: patient and staff perspective. |
| Q34251665 | Psychiatric disorder as a risk factor for cancer: different analytic strategies produce different findings. |
| Q57016807 | Psychiatric disorders and the ICU: gaps and opportunities |
| Q37236168 | Psychotic symptoms are associated with physical health problems independently of a mental disorder diagnosis: results from the WHO World Health Survey |
| Q36067581 | Psychotic symptoms in Kenya--prevalence, risk factors, and relationship with common mental disorders |
| Q37892448 | Quality assessment of physical activity recommendations within clinical practice guidelines for the prevention and treatment of cardio-metabolic risk factors in people with schizophrenia |
| Q41729808 | Quality of life and clinical characteristics in a nonselected sample of patients with schizophrenia. |
| Q26863435 | Randomized controlled trials in schizophrenia: opportunities, limitations, and trial design alternatives |
| Q51838849 | Recent Swedish clinical practice guidelines for prevention and management of metabolic risk. |
| Q35906535 | Reducing psychotropic pharmacotherapy in patients with severe mental illness: a cluster-randomized controlled intervention study |
| Q37903156 | Register-based studies of mental disorders |
| Q38266651 | S3 guideline on psychosocial therapies in severe mental illness: evidence and recommendations |
| Q37834002 | Schizoaffective disorder: a review of current research themes and pharmacological management |
| Q99632782 | Schizophrenia |
| Q38003844 | Schizophrenia and the immune system: pathophysiology, prevention, and treatment |
| Q36809816 | Schizophrenia is associated with excess multiple physical-health comorbidities but low levels of recorded cardiovascular disease in primary care: cross-sectional study |
| Q35144224 | Schizophrenia, cancer and obstetric complications in an evolutionary perspective-an empirically based hypothesis |
| Q22251476 | Schizophrenia, “Just the Facts”: What we know in 2008 |
| Q37727560 | Schizophrenia--time to commit to policy change |
| Q45231071 | Screening for cardiovascular risk in patients with severe mental illness in primary care: a comparison with patients with diabetes |
| Q91999730 | Second-generation antipsychotic drugs and short-term somatic serious adverse events: a systematic review and meta-analysis |
| Q37133664 | Secondary effects of antipsychotics: women at greater risk than men. |
| Q41681860 | Self-Reported and Interviewer-Rated Oral Health in Patients With Schizophrenia, Bipolar Disorder, and Major Depressive Disorder |
| Q38866414 | Severe mental illness and type 2 diabetes: using theory and research evidence to develop complex behaviour change interventions |
| Q35096571 | Somatic diseases and conditions before the first diagnosis of schizophrenia: a nationwide population-based cohort study in more than 900 000 individuals |
| Q50704041 | Stigma and discrimination against people with schizophrenia related to medical services. |
| Q93051349 | Stigmatizing Attitudes Towards Mental Disorders Among Non-Mental Health Professionals in Six General Hospitals in Hunan Province |
| Q90111352 | Stigmatizing attitudes of tertiary hospital physicians towards people with mental disorders in Saudi Arabia |
| Q33614663 | Study on psychoeducation enhancing results of adherence in patients with schizophrenia (SPERA-S): study protocol for a randomized controlled trial |
| Q51847420 | Swedish clinical guidelines--prevention and management of metabolic risk in patients with severe psychiatric disorders. |
| Q38839251 | Systematic review of self-management in patients with schizophrenia: psychometric assessment of tools, levels of self-management and associated factors |
| Q59052397 | The Concept of Schizophrenia: From Unity to Diversity |
| Q37743682 | The Influence of Psychosocial Dysfunctions in Chronic Schizophrenia Patients in Remission: A Hospital-Based Study |
| Q92032782 | The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness |
| Q43481544 | The Mental Health Nurse Incentive Program: the benefits from a client perspective |
| Q34849286 | The association between physical health and delusional-like experiences: a general population study |
| Q33609974 | The effectiveness and safety of amisulpride in Chinese patients with schizophrenia who switch from risperidone or olanzapine: a subgroup analysis of the ESCAPE study |
| Q51368998 | The functional exercise capacity is correlated with global functioning in patients with schizophrenia. |
| Q38954276 | The future of mental health nursing: are we barking up the wrong tree? |
| Q37920920 | The high prevalence of poor physical health and unhealthy lifestyle behaviours in individuals with severe mental illness |
| Q38190416 | The interface of physical and mental health. |
| Q37771646 | The need for routine physical health care in schizophrenia |
| Q41421037 | The perplexing issue of severe mental illness, physical health screening and primary care in England |
| Q92392729 | The prevalence and associated factors of depression among patients with schizophrenia in Addis Ababa, Ethiopia, cross-sectional study |
| Q37079080 | The prevalence and mechanisms of metabolic syndrome in schizophrenia: a review |
| Q38237481 | The prevalence of pain in bipolar disorder: a systematic review and large-scale meta-analysis |
| Q40199451 | The prevalence of schizophrenia in mainland China: evidence from epidemiological surveys |
| Q36282575 | The psychiatric inpatient physical health assessment sheet (PIPHAS): a useful tool to improve the speed, efficiency, and documentation of physical examination in new psychiatric inpatients |
| Q104577225 | The somatic care situation of people with mental illness |
| Q38718345 | Therapeutic improvements expected in the near future for schizophrenia and schizoaffective disorder: an appraisal of phase III clinical trials of schizophrenia-targeted therapies as found in US and EU clinical trial registries |
| Q37332227 | Transcriptome study of differential expression in schizophrenia |
| Q83214881 | Two-stage case-control association study of polymorphisms in rheumatoid arthritis susceptibility genes with schizophrenia |
| Q33902514 | Understanding the problems developing a healthy living programme in patients with serious mental illness: a qualitative study. |
| Q33464064 | Unmet need for mental health care in schizophrenia: an overview of literature and new data from a first-admission study |
| Q35116464 | Use of GP services by patients with schizophrenia: a national cross-sectional register-based study |
| Q30710247 | Use of health care services by people with mental illness: secondary data from three statutory health insurers and the German Statutory Pension Insurance Scheme |
| Q92451164 | Vitamin D supplementation compared to placebo in people with First Episode psychosis - Neuroprotection Design (DFEND): a protocol for a randomised, double-blind, placebo-controlled, parallel-group trial |
| Q38504254 | Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management |
| Q36555343 | Weight gain, metabolic disturbances, and physical health care in a Brazilian sample of outpatients with schizophrenia |
| Q56783533 | What a tangled web we weave: ethical and legal implications of deception in recruitment |
| Q55023835 | What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia? |
| Q46685755 | Where are patients who have co-occurring mental and physical diseases located? |
| Q47725026 | World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia - a short version for primary care |
| Q83130945 | [Metabolic disorders under antipsychotic treatment] |
| Q86565948 | [Pain therapy in patients with schizoaffective disorder and cancer] |
| Q60621254 | [Somatic morbidity in the mentally ill] |
| Q37707755 | miRNAs and their role in the correlation between schizophrenia and cancer (Review). |
Search more.